Deirdre A Conroy
Manage Your Profile
About
Deirdre Conroy is a Clinical Professor in the University of Michigan Department of Psychiatry. She obtained her undergraduate degree in biopsychology from Simmons College in Boston, MA and her Ph.D. in psychology from The City University of New York. She completed her clinical training in Sleep Medicine at Columbia Presbyterian Medical Center and Methodist Hospital in New York. She is board certified in sleep disorders medicine, behavioral sleep medicine, and cognitive behavioral therapy. As a clinical sleep psychologist and the Clinical Director of the Behavioral Sleep Medicine Clinic, she focuses on behavioral and cognitive interventions for sleep disorders such as insomnia and circadian rhythm sleep/wake disorders. She is also involved in the clinical education of trainees at various levels, through one-on-one clinical training, elective rotations, and mentorships. Her research interests are broadly in the role of insomnia in mental health and substance use. She is active on various committees throughout the Department of Psychiatry and currently serves as the department’s Wellness Advocate.
Areas of Interest
- Relationship between sleep disturbances and substance use disorders
- Childhood sleep problems and early onset of substance use
Clinical Interests
- Sleep Disorders
- Behavioral Sleep Medicine
- Cognitive Behavioral Therapy for Insomnia
Center Memberships
-
Center MemberEisenberg Family Depression Center
Recent Publications
-
Aday J, McAfee J, Conroy D, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Geller J, Harte S, Pouyan N, Glynos N, Baker A, Guss J, Davis A, Burgess H, Mashour G, Clauw D, Boehnke K. 2025 Apr 9;Journal ArticlePreliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
DOI:10.3389/fpain.2025.1527783 -
Swanson LM, Schubert JR, Raglan GB, Conroy DA. Current Psychiatry Reports, 2025 Apr 1; 27 (4): 161 - 175.Journal ArticleChronotherapeutic Treatments for Psychiatric Disorders: A Narrative Review of Recent Literature
DOI:10.1007/s11920-025-01586-9 PMID: 39913073 -
Braley TJ, Ehde DM, Alschuler KN, Little R, Ng YT, Zhai Y, von Geldern G, Chervin RD, Conroy D, Valentine TR, Romeo AR, LaRocca N, Hamade M, Jordan A, Singh M, Segal BM, Kratz AL. The Lancet Neurology, 2024 Nov 1; 23 (11): 1108 - 1118.Journal ArticleComparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trial
DOI:10.1016/S1474-4422(24)00354-5 PMID: 39424559 -
Fatabhoy MG, Davis MT, Thomas KA, Schubert JR, Conroy D, Bonar E, Walton M, Chermack S, Sexton MB. 2024 Nov 3;Proceeding / Abstract / PosterMagnitude matters: Substance use, mental health, and chronic pain's relationship with Veterans’ poor sleep quality
-
Warren R, Burrow J, Conroy DA, Lukela J, Kahn DA. Journal of Psychiatric Practice, 2024 Sep 11; 20 (5): 379 - 388.Journal Article"I Didn't Know Cognitive Therapy was Deep": A Case Study of Sudden and Lasting Gains in Cognitive-Supportive Therapy of Depression
-
Aday J, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke K. 2024 Aug 5;Proceeding / Abstract / PosterPreliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, proof-of-concept clinical trial
-
Swanson LM, de Sibour T, DuBuc K, Conroy DA, Raglan GB, Lorang K, Zollars J, Hershner S, Arnedt JT, Burgess HJ. Journal of Clinical Sleep Medicine, 2024 Oct 1; 20 (7): 1131 - 1140.Journal ArticleLow-dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time: preliminary findings
DOI:10.5664/jcsm.11076 -
Ilgen M, Arnedt JT, Conroy D, Yeagley E, Bohnert K. Drug and Alcohol Dependence, 2024 Jul 14; 260: 110133Journal ArticleS22 Results of Pilot Randomized Controlled Trial of Cognitive Behavioral Therapy for Insomnia to Reduce Cannabis Use
DOI:10.1016/j.drugalcdep.2023.110133